EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Developing a potent vaccine against Helicobacter pylori : critical considerations and challenges

Faria Hasanzadeh Haghighi iD, Shaho Menbari iD, Roghayeh Mohammadzadeh iD, Abbas Pishdadian iD, Hadi Farsiani iD

Expert Reviews in Molecular Medicine · 2025 · 27

DOI: 10.1017/erm.2024.19 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 25.11.2024. Verfasst von Faria Hasanzadeh Haghighi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Bacterial Vaccines, Vaccine Development. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori ( H. pylori) is closely associated with gastric cancer and peptic ulcers. The effectiveness of antibiotic treatment against H. pylori is diminished by the emergence of drug-resistant strains, side effects, high cost and reinfections. Given the circumstances, it is imperative to develop a potent vaccination targeting H. pylori. Understanding H. pylori ’s pathogenicity and the host’s immune response is essential to developing a vaccine. Furthermore, vaccine evaluation necessitates the careful selection of design formulation. This review article aims to provide a concise overview of the considerations involved in selecting the optimal antigen, adjuvant, vaccine delivery system and laboratory animal model for vaccine formulation. Furthermore, we will discuss some significant obstacles in the realm of developing a potent vaccination against H. pylori.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsBacterial VaccinesVaccine DevelopmentHumansAnimalsAntigens, Bacterial

Stichwörter der Autor:innen

Helicobacter pylori vaccinesadjuvantsanimal modelsantigensdelivery system

Substanzen

Bacterial VaccinesAntigens, Bacterial

Autor:innen und Institutionen

  • Department of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Laboratory Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Department of Immunology, School of Medicine, Zabol University of Medical Sciences, Zabol, Iran.
  • Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Faria Hasanzadeh Haghighi, Shaho Menbari, Roghayeh Mohammadzadeh, Abbas Pishdadian, Hadi Farsiani

Zitieren

APA

Hasanzadeh Haghighi, F., Menbari, S., Mohammadzadeh, R., Pishdadian, A., & Farsiani, H. (2025). Developing a potent vaccine against Helicobacter pylori : critical considerations and challenges. Expert Reviews in Molecular Medicine, 27. https://doi.org/10.1017/erm.2024.19

Vancouver

Hasanzadeh Haghighi F, Menbari S, Mohammadzadeh R, Pishdadian A, Farsiani H. Developing a potent vaccine against Helicobacter pylori : critical considerations and challenges. Expert Reviews in Molecular Medicine. 2025;27. doi:10.1017/erm.2024.19

BibTeX
@article{HasanzadehHaghighi2025,
  author = {Hasanzadeh Haghighi, Faria and Menbari, Shaho and Mohammadzadeh, Roghayeh and Pishdadian, Abbas and Farsiani, Hadi},
  title = {Developing a potent vaccine against Helicobacter pylori : critical considerations and challenges},
  journal = {Expert Reviews in Molecular Medicine},
  year = {2025},
  volume = {27},
  doi = {10.1017/erm.2024.19}
}
Kostenlos starten →